文献速递腹部泌尿生殖MRCT

常规MRI联合DWI序列检测可切除胰腺导管癌且肝脏CT正常患者的肝转移:一项前瞻性多中心研究

Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study.
PubMed 文献 · AJR Am J Roentgenol · 2018-09-21

这项前瞻性多中心研究纳入2011年3月至2013年7月间118例 potentially 可切除胰腺导管癌且CT肝脏正常的患者,术前MRI在16例中发现了CT未显示的肝脏病灶,其中12例(10.2%)为肝转移,且除1例外肝转移灶均小于10mm;基于患者的敏感度为80.0%、特异度为96.1%、阳性预测值为75.0%、阴性预测值为97.1%。作者认为与CT相比,术前MRI提高了肝转移检出,可能改变10%患者的管理及不必要的剖腹探查和胰腺切除率。

要点

  • CT肝脏正常时,MRI可额外发现肝转移,且多数转移灶小于10mm
  • MRI诊断肝转移的敏感度80.0%,特异度96.1%,阴性预测值97.1%
  • MRI假阳性4例(3.4%),随访24个月以上均无肝转移

核心结论

  • 与CT相比,术前MRI提高了 potentially 可切除胰腺导管癌且CT肝脏正常患者的肝转移检出,可能改变10%患者的管理及不必要的剖腹探查和胰腺切除率。

研究设计与样本

  • 前瞻性多中心研究,2011年3月至2013年7月纳入118例 potentially 可切除胰腺导管癌且CT肝脏正常的患者,术前行MRI,以检出肝脏病灶的病理分析为参考标准。

关键影像表现/征象

  • MRI在16例中显示了CT未见的肝脏病灶,所有病灶在有和无DWI时均可见;肝转移灶除1例外均小于10mm;3例(2.9%)MRI正常者术中诊断包膜下肝转移。

诊断标准与关键数值

  • 基于患者的MRI检测肝转移敏感度80.0%(95%CI 51.9-95.7%),特异度96.1%(95%CI 90.4-98.9%),阳性预测值75.0%(95%CI 47.6-92.7%),阴性预测值97.1%(95%CI 91.6-99.4%)。

临床应用与阅片要点

  • 对 potentially 可切除胰腺导管癌且CT肝脏正常的患者,术前MRI有助于检出CT未显示的肝转移,尤其需关注小于10mm的病灶及包膜下区域。

局限性

  • MRI假阳性4例(3.4%),随访24个月或更长时间仍无肝转移
  • 3例(2.9%)MRI正常者术中诊断包膜下肝转移

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to evaluate the performance of systematic MRI with DWI for the detection of liver metastases (LM) in patients with potentially resectable pancreatic ductal carcinoma and normal liver findings at CT.

SUBJECTS AND METHODS: Patients with potentially resectable pancreatic ductal carcinoma and a normal liver at CT were enrolled in a prospective multicenter study between March 2011 and July 2013 and underwent preoperative MRI. The reference standard was pathologic analysis of detected hepatic lesions.

RESULTS: A total of 118 patients were enrolled. MRI depicted liver lesions that were not visible at CT in 16 patients. All lesions were visualized both with and without DWI. Lesions were LM in 12 (10.2%) patients and were confirmed in seven patients by preoperative biopsy, four by intraoperative frozen section, and one at 6-month follow-up evaluation after pancreatic resection. All but one liver metastatic lesion diagnosed with MRI were smaller than 10 mm. Four of 118 (3.4%) patients had a false-positive diagnosis of LM at MRI and remained LM free after a follow-up period of 24 months or longer. Three of 102 (2.9%) patients with normal MRI findings had subcapsular LM that were diagnosed intraoperatively. At follow-up, 99 of 118 (83.9%) patients were LM free after a mean of 24 months. The patient-based sensitivity of MRI for the detection of LM was 80.0% (95% CI, 51.9-95.7%); specificity, 96.1% (95% CI, 90.4-98.9%); positive predictive value, 75.0% (95% CI, 47.6-92.7%); and negative predictive value, 97.1% (95% CI, 91.6-99.4%).

CONCLUSION: Compared with CT, preoperative MRI improves the detection of LM in patients with potentially resectable pancreatic ductal carcinoma and may change management and the rate of unnecessary laparotomy and pancreatectomy for 10% of patients.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Marion-Audibert AM, Vullierme MP, Ronot M, et al. Routine MRI With DWI Sequences to Detect Liver Metastases in Patients With Potentially Resectable Pancreatic Ductal Carcinoma and Normal Liver CT: A Prospective Multicenter Study. AJR Am J Roentgenol. 2018. PMID: 30240298. doi:10.2214/AJR.18.19640

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。